Timor-Leste clears trachoma, ending the disease as a problem across South-East Asia
WHO validated Timor-Leste's elimination of trachoma, the last suspected focus in its South-East Asia Region. A 2025 survey of 4,949 young children found no transmission requiring intervention.
The World Health Organization announced on 3 September that it has validated Timor-Leste as having eliminated trachoma as a public health problem [s1]. Because Timor-Leste was the last country in WHO's South-East Asia Region where the disease was still suspected to be endemic, the validation clears trachoma as a public health problem across the entire region [s1].
Trachoma is the world's leading infectious cause of blindness [s1]. It is caused by the bacterium Chlamydia trachomatis and spreads through contact with eye and nasal discharge from infected people [s1]. Repeated infections scar the inner eyelid until the eyelashes turn inward — a condition called trichiasis — and the lashes rub against the cornea, a process that can end in irreversible blindness [s1].
The evidence behind the validation
Validation is an evidentiary exercise, not a declaration. WHO's process is designed to establish both that the disease no longer poses a public health problem and that the health system can detect and manage future cases [s1].
Timor-Leste's case was built over roughly a decade. A first series of investigations between 2015 and 2017 examined children on Atauro Island, screened patients at eye clinics nationally, and conducted targeted house-to-house searches; none found trachoma [s1]. The country then generated fresh evidence: a 2025 survey analysed 4,949 samples from children aged one to five years across all 13 municipalities, and testing found no evidence of transmission at a level requiring trachoma-specific intervention [s1].
Young children are the right population to sample. In endemic areas, active inflammatory trachoma is most common among preschool-aged children, which makes their infection rate a sensitive early indicator of whether the bacterium is still circulating [s2].
What it means and what remains
With Timor-Leste's validation, it becomes the fourth country in the South-East Asia Region and the 33rd worldwide to eliminate trachoma as a public health problem [s1]. As of September 2026, 64 countries had eliminated at least one neglected tropical disease, including eight in the South-East Asia Region [s1].
Elimination as a public health problem is a specific, bounded claim. It does not mean the country will never see another case; it means transmission has fallen below the threshold at which trachoma functions as a population-level problem, and that services exist to handle individual cases. Timor-Leste says it will keep the capacity to identify and treat trichiasis and other eye disease through its eye-care system, including corrective surgery at the National Eye Centre at Hospital Nacional Guido Valadares in Dili, and will fold trachoma surveillance into its existing disease surveillance platforms [s1].
The disease's geography explains why the safeguards matter. Trachoma is strongly tied to poverty and to gaps in access to water, sanitation and health care, and it remains endemic in some of the world's most vulnerable communities [s1]. Globally it is still responsible for the blindness or visual impairment of about 1.9 million people and accounts for roughly 1.4% of all blindness [s2]. The burden falls unevenly by sex: women are blinded by trachoma up to four times as often as men, a gap generally attributed to their closer contact with infected children [s2].
The longer arc
Trachoma is one of the oldest recorded human diseases, and the tools to control it are not new. WHO adopted the "SAFE" strategy — surgery, antibiotics, facial cleanliness and environmental improvement — in 1993 [s2]. What Timor-Leste's result illustrates is less a breakthrough than the payoff from sustained, unglamorous public-health work: repeated surveys, integrated eye services, and improvements in water and sanitation carried out over years [s1].
For a global-health readership, the transferable point is that a whole WHO region can move from "suspected endemic somewhere" to "no longer a public health problem anywhere" — but only through country-by-country documentation. Regional elimination is the sum of national validations, each of which rests on the kind of field evidence Timor-Leste assembled.
Sources
- [s1] World Health Organization, "WHO validates Timor-Leste's elimination of trachoma as a public health problem," 3 September 2026.
- [s2] World Health Organization, "Trachoma" (fact sheet), accessed 3 September 2026.
Sources
- WHO validates Timor-Leste's elimination of trachoma as a public health problem — World Health Organization , September 3, 2026
- Trachoma (fact sheet) — World Health Organization , September 3, 2026
More on
Egypt clears trachoma, a disease documented there for more than 3,000 years
WHO validated Egypt as the 27th country to eliminate trachoma as a public health problem. Its programme began in 2002; the disease still blinds or impairs about 1.9 million people elsewhere.
Bhutan becomes first South-East Asia country validated free of dog-borne rabies
WHO validated Bhutan's elimination of dog-transmitted human rabies, a disease almost always fatal once symptoms appear. The country has recorded zero such deaths since June 2023.
Four in ten hospitalised mpox patients developed eye disease, a Congolese cohort finds
In South Kivu, ophthalmologists examined 310 patients with confirmed clade Ib mpox at four time points. Periorbital lesions and severe acute malnutrition tripled the risk of ocular involvement.
A hospital-linked mpox outbreak in Pakistan is killing infants at a 28% case fatality rate
WHO's latest mpox report shows global case counts holding steady, but flags a Sindh province cluster where nearly all deaths were in babies under six months old.